[CYCC] QoQ Quarter Result on 31-Mar-2013 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 35.31%
YoY- -4.30%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 299 309 264 212 5 38 146 61.05%
PBT -4,026 -5,746 1,248 -3,356 -5,067 -3,572 -3,704 5.69%
Tax -452 -730 -230 -258 -637 -419 -127 132.56%
NP -3,559 -5,004 1,429 -3,082 -4,764 -1,890 -3,577 -0.33%
Tax Rate - - 18.43% - - - - -
Total Cost 3,858 5,313 -1,165 3,294 4,769 1,928 3,723 2.39%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin -1,190.30 -1,619.42 541.29 -1,453.77 -95,280.00 -4,973.68 -2,450.00 -38.11%
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
EPS -44.87 -67.51 24.00 -75.55 -149.01 -53.81 -101.86 -42.01%
EPS Diluted -44.87 -67.51 24.00 -75.55 -149.01 -53.81 -101.86 -42.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.